Rukobia

Active Ingredient(s): Fostemsavir
FDA Approved: * July 2, 2020
Pharm Company: * VIIV HLTHCARE
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Rukobia Overview

Fostemsavir, sold under the brand name Rukobia, is an antiretroviral medication for adults living with HIV/AIDS who have tried multiple HIV medications and whose HIV infection cannot be successfully treated with other therapies because of resistance, intolerance or safety considerations.[2][4] The most common adverse reaction is nausea.[2][4][5] Severe adverse reactions included elevations in liver enzymes among p...

Read more Rukobia Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fostemsavir

Recent Rukobia Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Fostemsavir
  • Tablet, Extended Release: 600mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Rukobia: (1 result)

Sorted by National Drug Code
  • 49702-250 Rukobia 600 mg Oral Tablet, Film Coated, Extended Release by Viiv Healthcare Company

Other drugs which contain Fostemsavir or a similar ingredient: (1 result)